Public company buys startup using WashU’s AI technology to assess breast cancer risk
Prognosia, a firm founded by researchers at Washington University, has been acquired by Lunit, a publicly traded AI cancer screening firm in South Korea. Led by WashU Medicine researchers Graham Colditz and Shu “Joy” Jiang, Prognosia earlier this summer received
Read More...